Clinical Trial Detail

NCT ID NCT02639546
Title Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors (iMATRIXcobi)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

neuroblastoma

atypical teratoid rhabdoid tumor

adult malignant schwannoma

plexiform neurofibroma

malignant glioma

embryonal rhabdomyosarcoma

sarcoma

rhabdoid cancer

melanoma

malignant peripheral nerve sheath tumor

childhood malignant schwannoma

Therapies

Cobimetinib

Age Groups: adult child

No variant requirements are available.